Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Toxicology and Applied Pharmacology|March 24, 2023
Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactionsXin Lv, Zhe Wang, Zhen Wang, et al.
Current Drug Metabolism|May 28, 2024
Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1Xin Lv, Zhen Wang, Zhe Wang, et al.
Acta Pharmaceutica Sinica. B|January 30, 2020
Herbal drug discovery for the treatment of nonalcoholic fatty liver diseaseTingting Yan, Nana Yan, Ping Wang, et al.
Toxicology and Applied Pharmacology|May 26, 2021
Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferaseXiaoyu Wang, Zhe Wang, Xiaoyu Fan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 14, 2021
Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic InsightsYangliu Xia, Mingrui Yan, Ping Wang, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 11, 2022
Prediction of Drug-Drug Interaction Between Dabrafenib and Irinotecan via UGT1A1-Mediated GlucuronidationZhe Wang, Xiaoyu Wang, Zhen Wang, et al.
Cancer Chemotherapy and Pharmacology|November 7, 2019
The pharmacokinetic interaction between irinotecan and sunitinibLili Jiang, Li Wang, Zhongmin Zhang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 12, 2014
In vitro glucuronidation of Armillarisin A: UDP-glucuronosyltransferase 1A9 acts as a major contributor and significant species differencesDongxue Sun, Liangliang Zhu, Ling Xiao, et al.
Pageof 4